ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Kidney Diseases
Obesity

Diabetes trials near San Francisco, CA, USA:

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

San Francisco, California, United States and 22 other locations

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Enrolling
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

San Francisco, California, United States and 9 other locations

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...

Active, not recruiting
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Other: Intense Education Intervention
Duke University
Duke University

Stanford, California, United States and 43 other locations

The Validation of the Diabetes Deep Neural Network Score (DNN score) for Screening for Type 2 Diabetes Mellitus (diabetes)...

Active, not recruiting
Diabetes
Device: Application Validation
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

San Mateo, California, United States and 64 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Mountain View, California, United States and 24 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Concord, California, United States and 58 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Palo Alto, California, United States and 59 other locations

The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS).Participants will be asked to:...

Enrolling
Type1diabetes
Device: SteadiSet Extended Wear Infusion Set
Tandem Diabetes Care
Tandem Diabetes Care

Stanford, California, United States and 14 other locations

The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic...

Enrolling
Diabetic Foot
Diabetic Foot Ulcer
Device: Symphony™ plus Off-loading
Device: Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery

San Francisco, California, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems